If you need more lookups,
subscriptions start at $34 USD/month.
Fei Shen Location
Cambridge, MA, US
Fei Shen Work
2026 -now Head of BD and L USA and Global TA Inflammation @
2025 -2026 Member Board of Directors @
2024 -2026 Founding Member Board of Directors @
2023 -2026 Member Board of Directors @
2021 -2026 Member Board Of Directors, Co-Founder @
2021 -2026 Member Board of Directors @
2021 -2026 Managing Director, Head of Boehringer Ingelheim Venture Fund USA Inc @
2020 -2023 Member Board of Directors @
2020 -2021 Investment Director, Boehringer Ingelheim Venture Fund USA Inc @
2016 -2020 Head, In Vivo Pharmacology, Immunology and Respiratory Research @
2015 -2016 Senior Principal Scientist, Immunology and Respiratory Research @
2013 -2015 Senior Scientist, Pharmacology Department @
2010 -2013 Research Scientist, Pharmacology Department @
2007 -2010 Scientist, Pharmacology Department @
Fei Shen Education
Loyola University Chicago Stritch School of Medicine
Ph.D. (Neuropharmacology)
2002-2007
Eastern Illinois University
M.S. (Neuroscience)
2000-2002
East China University of Science and Technology
B.S. (Biochemistry)
1995-1999
Fei Shen Skills
In Vivo
Neuroscience
Research
Drug Discovery
Neuropharmacology
Pharmacology
Translational Research
R&D
Lifesciences
Biochemistry
Drug Development
Fei Shen Summary
Fei Shen, based in Cambridge, MA, US, is currently a Head of BD and L USA and Global TA Inflammation at Boehringer Ingelheim. Fei Shen brings experience from previous roles at Bodyport, ProTgen Inc, Libra Therapeutics and ArrePath. Fei Shen holds a 2002 - 2007 Ph.D. in Neuropharmacology @ Loyola University Chicago Stritch School of Medicine. With a robust skill set that includes In Vivo, Neuroscience, Research, Drug Discovery, Neuropharmacology and more. Fei Shen has 3 emails and 3 mobile phone numbers on RocketReach.
Looking for a different Fei Shen?
Find contact details for 700 million professionals.